Recordati S.p.A., a prominent player in the pharmaceutical industry, is headquartered in Luxembourg (LU) and operates extensively across Europe, North America, and other global markets. Founded in 1926, Recordati has established itself as a leader in the development and marketing of innovative medicines, particularly in the fields of rare diseases and specialty pharmaceuticals. The company’s core offerings include a diverse range of prescription drugs, with a strong emphasis on treatments for rare diseases, urology, and cardiovascular conditions. Recordati's commitment to research and development sets it apart, enabling the introduction of unique therapies that address unmet medical needs. With a robust market position, Recordati has achieved significant milestones, including strategic acquisitions and partnerships that enhance its portfolio and global reach.
How does RECORDATI's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
RECORDATI's score of 63 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, RECORDATI reported total carbon emissions of approximately 36,607,000 kg CO2e from Scope 1 and 9,811,000 kg CO2e from Scope 2, alongside 1,566,000 kg CO2e from Scope 3 emissions. This reflects a commitment to transparency in their environmental impact, with a total of about 48,984,000 kg CO2e for Scope 1 and 2 combined. RECORDATI has set ambitious climate targets, aiming for a 42% reduction in Scope 1 and Scope 2 greenhouse gas emissions by 2030, using 2023 as the baseline year. This target aligns with the Science Based Targets initiative (SBTi) and is designed to contribute to global efforts to limit warming to 1.5°C. Additionally, the company has committed to measuring and reducing its Scope 3 emissions, which encompass indirect emissions from its value chain. In previous years, RECORDATI's emissions have shown fluctuations, with Scope 1 emissions recorded at approximately 37,768,000 kg CO2e in 2022 and 36,607,000 kg CO2e in 2023. Scope 2 emissions were about 10,002,000 kg CO2e in 2022, indicating a focus on reducing energy-related emissions. Overall, RECORDATI's climate commitments reflect a proactive approach to sustainability, with clear targets aimed at reducing their carbon footprint and contributing to a more sustainable future.
Access structured emissions data, company-specific emission factors, and source documents
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|
Scope 1 | 34,458,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 12,384,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 3 | - | - | - | - | - | 0,000,000 | 0,000,000 | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
RECORDATI is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.